Home
Conditions
Mucinous Adenocarcinoma of the Rectum

Clinical trial condition

Mucinous Adenocarcinoma of the Rectum

Explore clinical trials studying Mucinous Adenocarcinoma of the Rectum. Study availability and eligibility vary by location and protocol.

11 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Mucinous Adenocarcinoma of the Rectum trial results

Completed

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

NCT01814501

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +18 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

NCT01652196

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +16 more
Locations: University of Michigan Ann Arbor, Michigan, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Montefiore Medical Center The Bronx, New York, United States

University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Completed

Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation

NCT02132858

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +17 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

NCT02232152

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +26 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer

NCT02270606

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +18 more
Locations: Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States

View Trial Details

Completed

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

NCT01643499

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of Unknown Primary, Adenocarcinoma of the Gallbladder, +67 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Evanston CCOP-NorthShore University HealthSystem Evanston, Illinois, United States

View Trial Details

Completed

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

NCT01923337

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +18 more
Locations: UC Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Completed

Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

NCT01726296

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +49 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer

NCT00060411

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +26 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

NCT00005036

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +26 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Mucinous Adenocarcinoma of the Rectum

Mucinous Adenocarcinoma of the Rectum trial results

Related conditions